This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Use of galantamine
ADMED_ACHEI_GALANTAMINE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
3834 |
4. Check minimum number of events
Min. number of events
3
|
3834 |
5. Include endpointsNone |
3834 |
6. Filter based on genotype QC (FinnGen only) |
3389 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Use of galantamine
based on the number of shared cases.
Similar with more cases:
- Use of anticholinesterases
- N06DA Anticholinesterases
- Unspecific neurodegenerative disorder
- Dementia
- Dementia, including avohilmo
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3389 | 1671 | 1718 |
| Unadjusted period prevalence (%) | 0.69 | 0.59 | 0.79 |
| Median age at first event (years) | 79.64 | 79.60 | 79.69 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3498
- Matched controls
- 34980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
6.2
307.7
733
1431
N06DX01
ATC
memantine; oral
11.3
307.7
1966
3578
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
6.6
307.7
802
1502
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
8.5
307.7
1056
1700
G30.8
ICD-10 Finland
Other Alzheimer disease
8.1
307.7
643
952
N06DA03
ATC
rivastigmine; oral, transdermal
5.7
307.7
832
1822
P20
ICPC
Memory disturbance
7.6
307.7
2161
6135
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
12.2
307.7
847
891
N06DA04
ATC
galantamine; oral
+∞
307.7
3498
147
G30.1
ICD-10 Finland
Alzheimer disease with late onset
9.4
307.7
1620
2944
SPAT1053
SPAT
Memory test
3.7
303.0
1530
6087
N05AX08
ATC
risperidone; systemic
4.4
292.7
931
2681
N06DA02
ATC
donepezil; oral
4.0
258.2
912
2811
P70
ICPC
Dementia
6.0
256.7
495
930
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
224.3
965
3366
G30
ICD-10 Finland
Alzheimer disease
7.2
167.0
258
383
G30.0
ICD-10 Finland
Alzheimer disease with early onset
9.6
153.0
184
202
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
8.0
129.7
180
236
F06.7
ICD-10 Finland
Mild cognitive disorder
4.0
118.2
362
978
N05AH04
ATC
quetiapine; oral
2.7
109.1
740
3205
AXX01, ,
SPAT
3.7
106.4
373
1104
F03
ICD-10 Finland
Unspecified dementia
3.0
100.2
522
1963
A28
ICPC
Limited function/disability NOS
2.2
98.4
1368
8041
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
6.9
94.9
150
227
SPAT1216
SPAT
Assessment of functional ability
2.2
92.1
1061
5762
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
4.9
86.2
198
426
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.1
81.4
989
5442
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
7.4
79.3
116
161
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.8
76.4
419
1608
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
4.3
70.4
186
447
SPAT1301
SPAT
No procedures
1.9
68.9
1430
9376
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
68.4
558
2588
SPAT1234
SPAT
Support of social functional capacity
2.6
65.7
429
1793
F0019, G301,
ICD-10 Finland
5.5
65.4
128
239
SPAT1254
SPAT
Administration of medicine
2.0
64.3
865
4880
L28
ICPC
Limited function/disability (L)
1.9
62.4
1146
7172
N06AB10
ATC
escitalopram; oral
2.2
56.4
575
2909
N06AX26
ATC
vortioxetine; oral
3.0
55.4
258
901
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
6.0
52.6
94
161
N06AX11
ATC
mirtazapine; oral
1.8
51.5
1272
8594
N05BA04
ATC
oxazepam; oral
1.8
49.7
1072
6950
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
49.0
641
3543
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.0
48.3
611
3334
R53
ICD-10 Finland
Malaise and fatigue
1.7
43.6
1107
7459
N02BE01
ATC
paracetamol; systemic, rectal
2.1
42.5
3076
27260
U04
ICPC
Incontinence urine
2.2
42.2
396
1926
R41.3
ICD-10 Finland
Other amnesia
2.7
40.4
228
881
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
37.7
1471
10947
AA1AD, ,
SPAT
5.2
37.5
78
154
AA1AD
NOMESCO Finland
CT of head and brain
1.6
36.5
1368
10060
SPAT1304
SPAT
Counselling and guidance related to ageing
1.9
36.1
537
3073
F05.1
ICD-10 Finland
Delirium superimposed on dementia
4.2
35.9
96
233
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
35.3
1117
7877
N27
ICPC
Fear of neurological disease other
3.4
34.9
126
377
WYA20
NOMESCO Finland
Home visit
2.9
34.4
170
612
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
5.5
32.9
64
119
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.3
32.3
272
1262
SPAT1101
SPAT
Orthostatic test
2.1
32.0
314
1548
SPAT1246
SPAT
Screening of depression or other psychiatric problem
3.3
31.3
122
383
XA800
NOMESCO Finland
Neuropsychological investigation
3.4
29.9
111
338
SPAT1229
SPAT
Assessment of need for aid
1.9
29.5
438
2494
TAB00
NOMESCO Finland
Lumbar puncture
2.9
29.4
143
510
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
29.4
846
5783
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
7.6
28.4
40
53
F0009, G300,
ICD-10 Finland
6.8
28.4
44
65
A29
ICPC
General symptom/complaint other
1.7
28.4
604
3819
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
26.7
760
5167
A04
ICPC
Weakness/tiredness general
1.6
25.6
705
4747
F01.9
ICD-10 Finland
Vascular dementia, unspecified
2.6
25.1
148
584
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
25.0
1110
8300
SPAT1252
SPAT
Overall medication plan or its review
1.9
24.8
359
2024
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.8
24.7
376
2152
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
24.6
482
2970
SPAT1263
SPAT
Sampling
1.5
24.3
1428
11263
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
24.1
412
2443
130
Kela drug reimbursment
Malignant tumour
0.3
23.9
85
2424
I95.1
ICD-10 Finland
Orthostatic hypotension
2.0
23.1
278
1474
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
23.0
1131
8600
R42
ICD-10 Finland
Dizziness and giddiness
1.5
22.3
1011
7552
SPAT1360
SPAT
Extensive global examination
1.9
22.1
311
1735
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
22.1
374
2208
G04BD12
ATC
mirabegron; oral
1.6
21.8
546
3579
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
21.8
1433
11463
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
21.8
1240
9667
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
21.5
622
4219
SPAT1172
SPAT
Guidance concerning hydration
2.3
21.3
172
783
A98
ICPC
Health maint/preventive medicine
1.6
21.3
2883
26259
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
21.3
1046
7925
N03AG01
ATC
valproic acid; systemic, rectal
2.2
20.8
183
863
S06.0
ICD-10 Finland
Concussion
1.7
20.6
396
2423
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
20.5
295
1657
R41.0
ICD-10 Finland
Disorientation, unspecified
2.1
19.8
205
1029
C10AA01
ATC
simvastatin; oral
1.4
19.1
1909
16265
N05AD01
ATC
haloperidol; systemic
2.2
18.5
160
750
SPAT1310
SPAT
Counselling related to known health issue
1.4
17.5
1008
7803
SPAT1260
SPAT
Consultation of another employee
1.5
17.5
618
4364
AA1CG, ,
SPAT
4.2
17.4
46
111
N05AH03
ATC
olanzapine; systemic
2.2
17.4
152
715
SPAT1312
SPAT
General health counselling
1.4
16.3
945
7308
F0014, G301,
ICD-10 Finland
5.3
16.1
32
61
N06AB06
ATC
sertraline; oral
1.8
15.9
254
1471
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
4.4
15.9
39
89
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
4.7
15.9
36
77
H02AB02
ATC
dexamethasone; systemic
0.4
15.8
108
2332
N02AA05
ATC
oxycodone; systemic
1.4
15.8
881
6765
F009, G309,
ICD-10 Finland
3.6
15.6
51
144
G04CA02
ATC
tamsulosin; oral
1.4
15.2
1038
8230
S01.0
ICD-10 Finland
Open wound of scalp
1.6
15.2
337
2136
SPAT1139
SPAT
Nutrition survey
2.0
15.1
161
817
N29
ICPC
Neurological sympt/complt other
2.7
15.1
81
306
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.6
15.1
401
2654
R55
ICD-10 Finland
Syncope and collapse
1.5
14.8
514
3605
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.0
14.6
153
773
J01DB01
ATC
cefalexin; oral
1.4
14.5
2514
22815
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
14.4
250
1485
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
5.5
14.3
27
49
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
3.2
14.2
56
178
XF606, ,
SPAT
3.4
14.2
51
153
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
14.1
817
6291
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
14.0
250
1496
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.6
13.8
324
2080
F01.2
ICD-10 Finland
Subcortical vascular dementia
3.3
13.8
51
156
AA1BG, ,
SPAT
3.0
13.8
61
208
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
13.6
373
5427
N06AB04
ATC
citalopram; systemic
1.4
13.6
642
4771
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
13.6
241
1440
C10AA05
ATC
atorvastatin; oral
1.3
13.5
1574
13437
N17
ICPC
Vertigo/dizziness
1.5
13.0
532
3848
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
13.0
219
1289
SPAT1307
SPAT
Psychosocial counselling and guidance
2.4
13.0
89
379
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
12.8
384
2608
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.1
12.8
121
589
R1250, ,
SPAT
2.1
12.7
117
564
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
5.5
12.6
24
44
J01CA08
ATC
pivmecillinam; oral
1.3
12.5
1280
10698
F00
ICD-10 Finland
Dementia in Alzheimer disease
4.2
12.5
33
80
SPAT1167
SPAT
Insertion of urinary catheter
1.8
12.4
181
1021
F0029, G308,
ICD-10 Finland
5.0
12.4
26
52
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
4.9
12.4
27
56
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
12.3
199
1159
SPAT1251
SPAT
Organisation of medication
1.8
12.0
180
1025
N30.0
ICD-10 Finland
Acute cystitis
1.4
11.8
628
4755
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
11.4
176
1010
W19
ICD-10 Finland
Unspecified fall
1.5
11.0
379
2649
SPAT1262
SPAT
Handing over of treatment supplies
1.4
10.9
617
4711
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
10.8
670
5195
SPAT1325
SPAT
Vaccination
1.3
10.6
1284
10906
F01
ICD-10 Finland
Vascular dementia
3.5
10.3
34
97
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
10.2
245
1584
A99
ICPC
Disease/condition unspecnature/site
1.5
10.1
350
2448
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.7
10.0
178
1064
E0000UV, ,
ATC
1.3
10.0
1227
10420
A06AD11
ATC
lactulose; oral
1.3
9.9
737
5860
G04CB01
ATC
finasteride; oral
1.4
9.9
529
3999
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
9.7
604
4676
JN4BD
NOMESCO Finland
Extensive body CT
0.6
9.6
167
2709
R5110, ,
SPAT
1.5
9.6
352
2488
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
3.9
9.6
27
69
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
9.4
8
436
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
0.1
9.4
*
344
F01.8
ICD-10 Finland
Other vascular dementia
5.2
9.4
19
37
201
Kela drug reimbursment
Chronic cardiac insufficiency
0.6
9.4
121
2122
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.3
9.1
21
750
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.0
9.1
102
530
Z75.5
ICD-10 Finland
Holiday relief care
2.3
8.9
63
273
R35
ICD-10 Finland
Polyuria
1.5
8.8
255
1720
WX402
NOMESCO Finland
General anaesthesia
0.7
8.7
260
3742
N28
ICPC
Limited function/disability (N)
2.2
8.7
73
341
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
8.7
1524
13425
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.3
8.6
22
742
C03DA01
ATC
spironolactone; oral
0.7
8.5
309
4290
S70.0
ICD-10 Finland
Contusion of hip
1.6
8.5
177
1105
F00.24
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type
7.3
8.4
19
26
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.3
8.4
24
763
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
8.4
379
2781
SPAT1050
SPAT
Extensive neurological examination
2.0
8.3
86
435
F00.2
ICD-10 Finland
Dementia in Alzheimer disease, atypical or mixed type
10.8
8.3
15
14
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.7
8.3
447
5811
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.7
8.2
380
5064
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.3
8.1
532
4142
F00.29
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms
11.7
8.1
14
12
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.9
1242
10773
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
7.8
237
1614
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.8
7.8
106
588
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.0
7.7
*
225
A04AA02
ATC
granisetron; systemic, transdermal
0.4
7.7
49
1083
R32
ICD-10 Finland
Unspecified urinary incontinence
1.8
7.5
118
684
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
7.5
487
3786
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.2
7.4
1343
11804
K08.3
ICD-10 Finland
Retained dental root
1.5
7.4
231
1581
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
0.5
7.4
61
1230
Z04.3
ICD-10 Finland
Examination and observation following other accident
2.2
7.2
60
280
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
2.0
7.2
75
382
SPAT1014
SPAT
Treatment of eyes
1.9
7.2
84
445
A27
ICPC
Fear of other disease NOS
1.6
7.1
175
1138
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
7.0
128
774
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
4.4
7.0
17
39
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.4
6.9
366
2756
I50.1
ICD-10 Finland
Left ventricular failure
0.6
6.9
105
1756
KED22
NOMESCO Finland
Transurethral resection of prostate
1.4
6.8
260
1853
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.7
6.8
246
3418
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
1.8
6.7
87
476
S01.3
ICD-10 Finland
Open wound of ear
2.4
6.7
43
180
OAB41, ,
SPAT
2.6
6.7
38
150
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
0.5
6.6
71
1313
R4110
NOMESCO Finland
Physiotherapy
0.8
6.6
577
7054
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.2
6.5
814
6862
J30.0
ICD-10 Finland
Vasomotor rhinitis
1.9
6.5
73
381
S72.0
ICD-10 Finland
Fracture of neck of femur
1.4
6.5
240
1699
F32
ICD-10 Finland
Depressive episode
1.8
6.5
86
474
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
6.5
528
4230
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.5
6.5
167
1099
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
6.5
1742
15838
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.2
6.5
1148
10040
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.3
6.4
384
2947
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.1
6.4
*
217
F01.23
ICD-10 Finland
Subcortical vascular dementia other additional symptoms, mainly depression
7.4
6.4
14
19
N40
ICD-10 Finland
Hyperplasia of prostate
1.2
6.4
894
7631
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
6.4
2406
22558
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.4
6.3
244
1744
F0024, G308,
ICD-10 Finland
11.0
6.3
11
10
SPAT1244
SPAT
Occupational therapy
2.4
6.3
40
167
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
18.0
6.3
9
5
G04BD11
ATC
fesoterodine; oral
1.7
6.3
115
698
I50.9
ICD-10 Finland
Heart failure, unspecified
0.8
6.2
615
7412
A04AA01
ATC
ondansetron; systemic, rectal
0.6
6.1
99
1633
J01EA01
ATC
trimethoprim; systemic
1.2
6.1
908
7790
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
6.1
328
2477
WW500
NOMESCO Finland
Blood transfusion
0.5
6.1
40
872
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.9
6.1
70
369
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
6.0
1398
12511
L01BC06
ATC
capecitabine; oral
0.4
6.0
26
672
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
167
203
8.59
128.06
1.0
1.0
393.36
319.01
ng/l
1.98
125
122
167
204
8.55
127.54
1.0
1.0
52.84
43.24
ng/l
1.27
122
121
167
204
8.55
127.54
1.0
1.0
603.21
658.40
ng/l
0.72
125
119
1410
8099
2.24
110.48
1.9
1.8
1215.29
1160.90
nmol/l
1.38
1062
5991
1720
11187
2.06
92.78
1.9
1.8
21.25
19.96
nmol/l
2.20
1411
9342
2162
15649
2.00
82.16
2.6
2.4
95.21
93.52
pmol/l
0.83
1178
8153
1856
13450
1.81
62.71
2.4
2.4
79.54
81.03
nmol/l
1.47
1574
11594
1173
7757
1.77
51.13
2.6
3.1
2.45
2.47
mmol/l
8.17
1060
6862
1170
7814
1.75
48.75
1.9
1.8
478.20
8943923.66
pmol/l
1.98
907
6228
1609
11963
1.64
43.23
2.4
3.3
2.36
2.35
mmol/l
1.05
1438
10617
174
579
3.11
40.50
1.2
1.3
485.68
610.47
mg/l
2.89
165
548
155
495
3.23
38.65
1.2
1.4
415.13
856.27
e6/l
0.73
113
403
154
490
3.24
38.63
1.2
1.3
3.53
41.81
e6/l
1.58
105
379
1987
15845
1.59
37.88
4.9
6.3
1.22
1.21
mmol/l
11.71
1758
14416
2749
23792
1.73
37.17
5.8
5.6
2.08
2.12
mu/l
0.42
2450
21210
2166
17692
1.59
36.69
5.0
7.1
1.22
1.21
mmol/l
11.25
1789
15069
2477
20912
1.63
36.34
6.4
6.2
3472.01
3207.62
e6/l
0.09
74
403
1415
10738
1.53
31.48
2.4
2.2
233.52
227.45
u/l
0.09
1329
10046
1726
13773
1.50
29.60
4.7
5.0
61.25
113.93
ng/l
0.97
1457
11365
998
7084
1.57
29.58
5.5
5.3
1.02
1.02
kg/l
3.28
696
4890
2889
25828
1.68
29.00
19.4
22.5
28.75
29.22
mg/l
0.29
2535
22647
2321
19926
1.49
26.00
4.3
4.4
15.32
15.32
pmol/l
0.00
2024
17580
2956
26773
1.67
25.98
25.1
28.0
139.79
139.38
mmol/l
12.25
2879
26144
2956
26791
1.67
25.70
25.2
28.3
4.00
4.02
mmol/l
3.41
2874
26129
2959
26867
1.66
25.03
27.1
30.5
84.25
87.42
umol/l
7.16
2897
26359
2959
26896
1.65
24.58
29.9
33.5
92.28
92.11
fl
1.22
2901
26386
2959
26897
1.65
24.56
30.3
34.1
38.93
38.45
%
5.39
2900
26375
2959
26897
1.65
24.56
30.0
33.6
232.92
237.31
e9/l
3.22
2873
26118
2959
26897
1.65
24.56
30.0
33.6
4.27
4.27
e12/l
0.03
2864
25997
2959
26899
1.65
24.53
30.2
33.9
129.32
128.50
g/l
2.37
2902
26417
2959
26904
1.65
24.45
30.0
33.6
7.15
7.13
e9/l
0.13
2862
25998
1196
9181
1.46
23.15
5.4
4.9
0.00
0.00
estimate
0.50
295
3036
1892
15870
1.42
22.14
5.0
4.9
0.02
0.39
estimate
0.67
331
3421
1882
15783
1.42
21.98
5.0
4.9
0.02
3.36
estimate
2.17
353
3638
1428
11469
1.41
21.02
2.4
2.3
—
—
—
0
0
1431
11514
1.41
20.77
5.1
5.2
2.32
0.58
estimate
0.44
271
2836
1848
15546
1.40
20.62
4.9
4.9
0.00
0.00
estimate
0.50
341
3464
1858
15663
1.40
20.37
3.4
4.7
35.00
34.01
g/l
13.16
1656
14419
947
7197
1.43
18.44
1.8
2.0
—
—
—
0
0
572
4003
1.51
16.81
9.1
9.3
—
—
—
0
0
2850
26238
1.47
16.61
11.4
13.3
22.11
22.97
u/l
1.06
2688
25068
271
1584
1.77
16.47
2.1
2.0
—
—
—
0
0
2135
18835
1.34
15.35
4.3
5.1
6.99
6.94
mmol/l
0.43
2058
17987
2310
20636
1.35
15.18
4.2
4.7
14.40
16.35
mm/h
6.98
2056
18826
249
1467
1.75
14.72
2.0
1.9
—
—
—
0
0
2675
24572
1.38
13.88
5.8
6.0
6.16
6.16
mmol/l
0.03
2290
21543
2598
23830
1.35
13.04
20.4
22.9
67.62
66.49
ml/min/173m2
2.57
2436
22439
2616
24062
1.35
12.59
7.6
7.7
41.47
41.08
mmol/mol
1.22
2302
21676
2450
22352
1.32
12.27
5.8
8.2
79.12
84.35
u/l
4.54
2239
20920
1949
17273
1.29
12.00
19.8
22.2
1.39
1.42
inr
1.72
1721
14704
931
7519
1.32
11.45
5.2
4.6
0.30
0.49
—
10
146
2629
24420
1.31
10.32
6.1
6.3
2.36
2.40
mmol/l
1.40
2293
21698
2437
22488
1.28
9.62
4.5
4.5
1.19
1.23
mmol/l
3.55
2080
19536
2549
23664
1.28
9.52
5.3
5.4
4.24
4.29
mmol/l
1.40
2230
21068
75
344
2.21
9.31
3.0
3.7
312.94
325.36
umol/l
0.32
63
291
482
3639
1.38
9.05
2.5
2.5
5.38
6.25
ug/l
0.45
383
3018
2516
23395
1.27
8.83
5.2
5.3
1.46
1.45
mmol/l
0.53
2184
20637
1182
10118
1.25
8.72
5.7
6.5
2.67
4.72
ug/l
4.15
1036
8876
301
2128
1.45
8.21
1.5
1.5
—
—
—
0
0
55
1188
0.45
8.09
3.4
3.5
1.70
1.69
mmol/l
0.01
55
1166
112
1926
0.57
8.08
3.3
4.2
1.74
1.53
%
0.55
107
1832
103
1778
0.57
7.55
3.5
4.3
0.86
0.86
%
0.01
97
1690
471
3655
1.33
7.34
5.3
5.3
35.42
34.55
%
0.82
293
2205
251
3521
0.69
7.30
3.6
5.5
10.08
12.25
mmol/l
5.74
232
3298
303
4091
0.72
7.06
2.8
3.8
26.60
23.10
ug/l
0.07
254
3430
782
9258
0.80
6.84
1.8
1.9
1.12
1.25
mmol/l
8.24
600
7450
1641
14801
1.20
6.76
3.1
3.3
49.17
58.30
u/l
3.53
1449
13271
359
4668
0.74
6.54
2.8
3.8
240.71
251.30
u/l
0.90
335
4348
76
1351
0.55
6.23
2.2
2.8
76.19
4017.68
u/ml
1.21
59
1149
1285
11400
1.20
6.14
3.8
3.8
57.99
90.63
e6/l
1.30
1038
8977
52
1024
0.50
5.96
3.5
3.7
8.77
7.94
mmol/l
0.74
52
1004
389
3028
1.32
5.92
2.5
2.6
0.68
0.57
e6/l
0.36
374
2938
947
8195
1.21
5.82
3.0
2.9
6.14
5.29
e6/l
0.92
877
7484
66
350
1.90
5.68
1.5
1.5
—
—
—
0
0
649
5445
1.24
5.35
1.7
1.9
—
—
—
0
0
1372
12356
1.18
5.32
4.5
4.5
131.62
138.18
e6/l
0.09
1048
9159
87
1426
0.60
5.30
2.7
2.6
—
—
—
0
0
287
3723
0.75
5.11
1.3
1.3
16.74
15.64
u/ml
0.06
84
1201
2079
19419
1.17
5.03
26.6
30.2
330.51
329.55
g/l
5.39
2054
19218
148
2125
0.68
4.91
5.2
7.7
16.30
15.53
%
3.23
143
2049
51
263
1.95
4.82
2.5
2.4
—
—
—
0
0
219
2913
0.74
4.63
2.0
2.4
32.72
38.07
u/l
1.83
184
2413
6
247
0.24
4.61
1.3
1.4
—
—
—
0
0
198
1452
1.39
4.49
1.6
1.5
1.67
1.67
%
0.02
163
1150
41
201
2.05
4.48
1.1
1.1
—
3.03
—
0
7
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
99
1507
0.65
4.43
1.7
2.5
0.39
0.35
iu/ml
0.31
48
870
78
1249
0.62
4.37
2.3
4.2
179.05
114.35
u/ml
0.38
72
1202
104
1562
0.66
4.37
1.7
1.8
1.56
1.47
g/l
0.07
90
1374
34
158
2.16
4.27
1.0
1.1
—
—
—
0
0
1085
12033
0.86
4.21
12.0
13.3
0.00
0.00
e9/l
2.65
890
9656
29
612
0.47
4.17
2.5
2.5
4.09
4.11
mmol/l
0.13
29
607
29
612
0.47
4.17
2.5
2.5
107.07
105.55
mmol/l
0.43
29
607
201
1498
1.36
4.15
2.1
2.1
0.00
0.00
estimate
-0.00
37
382
321
3989
0.78
4.11
1.3
1.3
44.12
39.30
iu/ml
0.14
99
1220
920
8157
1.17
4.09
4.9
5.3
22.22
22.50
%
0.21
513
4587
29
603
0.48
4.02
2.5
2.5
1.22
1.20
mmol/l
0.66
29
598
591
5057
1.20
3.95
1.7
1.9
—
—
—
0
0
48
843
0.56
3.90
1.3
1.5
—
—
—
0
0
192
1440
1.35
3.83
1.9
2.0
589.31
815.57
ug/l
0.39
179
1370
878
7808
1.17
3.71
4.2
4.5
1.25
0.26
estimate
0.47
248
2667
92
606
1.53
3.71
1.2
1.4
0.23
0.27
mg/l
0.40
38
211
353
4283
0.80
3.67
2.4
3.3
5.98
5.82
kpa
1.96
340
4162
702
7983
0.85
3.65
2.4
3.0
349.82
366.30
umol/l
3.54
555
6660
409
4877
0.82
3.60
3.1
4.9
0.98
1.05
mmol/l
6.07
369
4443
293
3599
0.80
3.41
1.9
2.5
66.62
65.49
g/l
1.86
244
3190
113
1582
0.70
3.34
2.1
3.0
41.76
94.73
mg/l
0.91
88
1348
25
510
0.49
3.34
1.7
1.2
—
—
—
0
0
13
38
3.43
3.30
4.8
2.7
0.69
0.53
u/field
0.20
13
38
113
1578
0.71
3.30
2.1
3.0
42.46
61.57
mg/l
0.61
89
1347
79
520
1.53
3.24
10.6
7.2
9.18
7.27
mmol/l
1.79
56
433
1125
10306
1.14
3.03
2.3
2.5
2.82
3.07
mg/l
3.36
931
8797
683
7672
0.86
2.97
3.2
4.2
81.41
80.85
%
0.23
673
7500
169
2173
0.77
2.89
1.5
1.7
1.67
1.54
g/l
1.00
139
1843
43
251
1.72
2.88
1.3
1.3
—
—
—
0
0
24
116
2.08
2.82
1.4
1.3
—
—
—
0
0
23
110
2.10
2.78
1.1
1.2
—
64.89
%
—
0
19
301
3602
0.82
2.76
2.2
2.9
4.31
4.30
kpa
0.02
292
3488
30
159
1.89
2.75
1.6
1.7
108.93
92.92
umol/l
0.73
30
159
18
382
0.47
2.75
1.6
2.0
2.75
3.13
mmol/l
0.52
11
282
1426
13321
1.12
2.71
3.1
3.6
1890.19
2169.89
ng/l
1.63
1214
11797
20
92
2.18
2.67
2.2
2.1
—
—
—
0
0
47
744
0.63
2.64
1.3
1.5
32.21
29.62
g/l
0.93
41
668
11
35
3.15
2.64
1.0
1.2
—
—
—
0
0
162
2064
0.77
2.61
1.3
1.2
—
—
—
0
0
511
5810
0.86
2.60
2.1
2.6
20.60
20.37
%
0.15
443
5312
13
305
0.42
2.59
2.1
1.2
161.12
159.12
au/ml
—
6
92
69
1003
0.68
2.59
1.5
1.6
—
—
—
0
0
40
652
0.61
2.55
1.2
1.4
—
—
—
0
0
355
4150
0.84
2.54
2.3
3.4
2.02
1.86
mmol/l
0.37
311
3558
32
179
1.79
2.51
1.9
2.2
14.49
26.02
umol/l
—
7
18
41
661
0.62
2.51
1.2
1.2
24.14
41.32
u/l
1.81
32
569
81
1135
0.71
2.49
1.6
2.5
0.00
0.00
g/l
-0.00
70
1048
20
95
2.11
2.48
2.0
2.1
—
—
—
0
0
88
1215
0.72
2.48
1.5
2.4
0.00
0.00
g/l
-0.00
72
1050
108
1440
0.74
2.44
1.9
2.9
2.22
4.61
ratio
1.30
68
886
1081
10015
1.11
2.30
2.3
2.6
64.66
68.46
u/l
0.16
979
9184
139
1766
0.78
2.23
1.6
2.4
4.27
4.16
g/l
0.90
107
1561
139
1763
0.78
2.20
1.6
2.4
3.90
3.72
g/l
0.83
107
1558
94
1257
0.74
2.20
1.5
2.4
0.00
0.06
g/l
2.15
77
1107
83
1128
0.73
2.16
1.4
1.3
279.94
238.93
u/ml
0.18
71
1026
140
1769
0.78
2.16
1.6
2.4
7.65
7.54
g/l
0.33
108
1559
36
574
0.62
2.15
1.2
1.3
—
—
—
0
0
557
6211
0.88
2.15
2.0
2.6
2.26
2.23
g/l
0.47
481
5641
1058
9827
1.11
2.13
3.8
3.7
0.50
0.57
e6/l
0.57
827
7545
10
37
2.71
2.07
1.0
1.2
—
—
—
0
0
166
1339
1.25
2.06
3.5
3.4
0.78
0.84
nmol/l
1.37
129
1062
515
5738
0.88
1.96
2.0
2.7
0.82
0.81
mmol/l
0.12
457
5283
169
1376
1.24
1.95
2.2
3.1
24.57
24.92
mmol/l
0.57
161
1349
124
1567
0.78
1.94
1.4
2.4
10.39
10.38
g/l
0.00
90
1341
20
360
0.55
1.93
1.7
1.2
—
19.81
—
0
8
55
783
0.70
1.92
3.7
5.5
104.00
104.86
mmol/l
0.68
48
705
160
1954
0.81
1.86
2.8
2.7
11.32
10.89
g/l
0.38
142
1755
26
431
0.60
1.86
4.2
3.5
—
—
—
0
0
37
564
0.65
1.85
1.2
1.4
—
—
—
0
0
44
646
0.68
1.83
1.3
1.4
1581.06
3091.27
e6/l
0.56
31
459
43
628
0.68
1.75
1.1
1.2
5.54
3.48
u/ml
—
7
63
62
849
0.73
1.75
1.2
1.4
—
—
—
0
0
43
627
0.68
1.74
1.1
1.2
4.13
5.64
u/ml
—
8
101
180
1496
1.21
1.74
1.3
1.3
—
—
—
0
0
10
215
0.46
1.69
1.4
1.4
—
—
—
0
0
10
215
0.46
1.69
1.4
1.4
—
—
—
0
0
605
6605
0.90
1.63
2.0
2.6
11.30
11.24
umol/l
0.08
525
6036
40
582
0.68
1.62
1.3
1.4
113847.83
60839.38
e6/l
0.53
23
337
292
2549
1.16
1.62
2.8
3.8
5.06
5.17
kpa
1.70
261
2382
123
1517
0.80
1.61
1.7
2.4
0.89
1.13
g/l
0.28
92
1252
421
4688
0.88
1.61
3.8
5.9
11.67
11.63
kpa
0.05
401
4458
13
63
2.07
1.59
1.0
1.1
—
—
—
0
0
255
2206
1.17
1.59
2.6
3.7
1.92
2.16
mmol/l
0.44
165
1605
24
386
0.62
1.56
1.3
1.3
11.96
12.71
u/l
0.10
24
348
422
4688
0.89
1.55
3.8
5.9
5.09
5.05
kpa
0.29
404
4464
14
71
1.98
1.53
1.0
1.1
—
—
—
0
0
775
8328
0.91
1.52
2.4
3.0
32.24
37.59
u/l
2.16
719
7742
24
383
0.62
1.52
3.5
3.6
13.90
11.66
index
—
10
190
7
27
2.60
1.51
1.1
1.0
—
—
—
0
0
9
182
0.49
1.50
2.9
3.5
0.33
1.16
%
—
9
182
32
477
0.67
1.49
1.2
1.4
—
—
—
0
0
56
756
0.74
1.49
1.4
1.6
—
—
—
0
0
64
847
0.75
1.49
1.2
1.4
—
—
—
0
0
15
81
1.86
1.40
1.1
1.2
0.49
0.47
ratio
—
7
46
14
249
0.56
1.37
1.0
1.1
—
32.97
—
0
18
226
2591
0.86
1.36
2.2
3.0
131.04
125.45
g/l
3.66
215
2524
37
525
0.70
1.35
1.2
1.3
—
—
—
0
0
1340
12796
1.08
1.34
2.6
3.2
131.96
151.46
ug/l
2.38
1165
11495
65
844
0.77
1.34
1.6
1.6
51.72
31.64
u/ml
—
10
116
0
39
0.00
1.33
0.0
17.6
—
5.08
—
0
39
26
393
0.66
1.32
1.4
1.5
—
—
—
0
0
51
376
1.36
1.32
1.9
1.7
22.78
29.40
u/ml
—
9
82
30
438
0.68
1.29
1.1
1.1
—
—
—
0
0
23
354
0.65
1.28
1.7
1.3
0.53
5.88
nmol/l
0.52
23
329
137
1627
0.84
1.28
1.6
2.4
2.90
3.01
g/l
0.65
105
1419
58
756
0.76
1.25
2.0
3.0
55.66
1072.09
u/ml
1.91
51
681
56
425
1.32
1.22
1.1
1.3
—
—
—
0
0
44
593
0.74
1.20
1.3
1.5
—
—
—
0
0
310
3447
0.89
1.20
1.9
2.5
9.24
10.29
umol/l
0.32
272
3001
182
2095
0.86
1.18
1.6
1.4
—
—
—
0
0
202
2306
0.87
1.17
4.0
7.1
24.24
24.29
mmol/l
0.10
192
2224
1305
13597
0.94
1.14
4.4
6.0
25.23
24.53
%
1.29
1201
12720
55
422
1.31
1.13
1.1
1.3
—
—
—
0
0
83
1019
0.81
1.12
3.3
3.8
0.86
1.88
index
2.32
42
513
18
111
1.62
1.12
1.1
1.0
—
—
—
0
0
33
457
0.72
1.09
1.4
1.5
—
—
—
0
0
54
416
1.30
1.09
1.1
1.3
—
—
—
0
0
8
41
1.95
1.08
1.4
1.1
—
—
—
0
0
330
2992
1.11
1.08
2.9
3.7
1.23
1.22
mmol/l
2.88
261
2550
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
128
1.57
1.08
1.1
1.2
—
—
—
0
0
1043
10932
0.93
1.08
3.8
4.1
7.29
9.70
mg/mmol
1.24
619
6857
1277
13295
0.94
1.07
4.4
5.8
59.43
59.92
%
0.69
1178
12539
400
4358
0.91
1.07
1.3
1.5
2.68
2.79
g/l
0.36
189
2357
76
936
0.81
1.07
1.8
1.6
4.24
7.40
iu/ml
1.17
23
224
13
74
1.76
1.06
1.0
1.4
1.16
1.17
mmol/l
0.16
13
74
15
242
0.62
1.06
1.1
1.2
107.13
106.19
pmol/l
0.02
15
242
35
476
0.73
1.05
1.2
1.7
18.53
24.57
ug/l
0.65
35
463
25
360
0.69
1.04
1.1
1.2
—
4.00
—
0
11
57
722
0.79
1.03
1.5
1.5
0.05
14.56
iu/ml
0.91
16
173
13
75
1.74
1.02
1.0
1.1
—
—
—
0
0
615
5760
1.08
1.02
3.4
3.7
0.84
0.89
ug/l
0.47
483
4270
19
286
0.66
1.00
1.1
1.2
—
—
—
0
0
18
272
0.66
0.97
1.9
2.2
683.33
621.28
ml
0.23
12
160
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
32
0.00
0.95
0.0
1.2
—
3413.82
—
0
22
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
264
2387
1.11
0.94
2.6
3.0
58.71
55.68
ml/min/173m2
0.88
121
1138
350
3808
0.91
0.93
2.6
3.3
191.16
282.99
ng/l
7.15
318
3498
9
52
1.73
0.92
1.0
1.0
—
—
—
0
0
190
2135
0.88
0.92
1.3
1.3
—
—
—
0
0
118
1014
1.17
0.90
2.1
3.0
7.99
7.68
kpa
1.49
111
986
301
3289
0.91
0.89
1.7
2.0
0.20
0.19
g/l
0.77
276
3001
434
4664
0.92
0.89
3.7
5.8
1.28
1.01
mmol/l
0.78
337
3753
8
42
1.91
0.88
1.4
1.1
—
—
—
0
0
161
1822
0.88
0.88
1.5
1.8
2.05
2.36
ug/l
0.17
123
1550
1020
10632
0.94
0.87
3.1
3.3
6.94
6.56
mmol/l
2.15
801
8683
52
414
1.26
0.86
1.1
1.4
—
—
—
0
0
43
548
0.78
0.85
1.4
2.1
3.16
3.17
ratio
0.03
36
447
52
415
1.26
0.84
1.1
1.3
—
—
—
0
0
22
308
0.71
0.83
1.4
1.4
21.02
30.43
ng/l
1.25
22
308
72
863
0.83
0.82
2.0
2.4
1.52
1.87
mg/l
4.87
60
734
95
1111
0.85
0.82
1.2
1.1
121.00
113.01
u/ml
0.05
28
355
33
433
0.76
0.82
1.2
1.4
—
—
—
0
0
603
5695
1.07
0.82
3.6
3.5
2.69
2.51
e6/l
0.19
330
2972
11
65
1.69
0.82
1.0
1.0
—
—
—
0
0
50
622
0.80
0.82
1.2
1.3
80.00
232.96
titre
—
8
54
52
417
1.25
0.82
1.1
1.3
—
—
—
0
0
757
7206
1.06
0.81
4.2
4.7
223.84
441.73
ng/l
0.98
652
6537
15
225
0.67
0.81
1.0
1.1
—
2.11
—
0
5
27
364
0.74
0.81
1.7
1.9
19.04
1213.41
u/ml
0.88
27
359
50
621
0.80
0.81
1.2
1.3
—
100.00
—
0
15
34
443
0.77
0.81
1.4
1.4
—
—
—
0
0
21
294
0.71
0.80
1.0
1.1
290.00
314.48
u/ml
—
10
153
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
5
96
0.52
0.78
1.0
1.4
—
—
—
0
0
5
98
0.51
0.77
2.0
2.1
0.59
0.61
mmol/l
—
5
98
5
98
0.51
0.77
1.0
1.4
1.46
1.55
g/l
—
5
98
1335
13769
0.95
0.76
2.4
3.0
—
—
estimate
—
0
0
13
197
0.66
0.75
1.2
1.2
—
—
—
0
0
92
1066
0.86
0.73
1.4
1.6
—
—
—
0
0
8
132
0.61
0.73
1.1
1.2
—
—
—
0
0
90
1044
0.86
0.73
1.4
1.7
36.13
38.74
u/l
0.60
76
868
15
219
0.68
0.73
1.1
1.3
—
—
—
0
0
144
1281
1.13
0.72
1.3
1.3
50.53
59.69
au/ml
—
7
87
27
202
1.34
0.72
1.1
1.2
—
1240.00
—
0
6
12
183
0.65
0.72
1.3
1.6
10.86
7.50
u/l
—
7
146
9
57
1.58
0.71
2.1
1.4
11.28
9.56
ug/l
—
9
57
5
27
1.85
0.68
1.0
1.0
1.60
1.68
umol/24h
—
5
27
9
59
1.53
0.68
1.0
1.1
—
—
—
0
0
16
226
0.71
0.66
3.9
3.7
—
—
—
0
0
53
637
0.83
0.66
3.0
4.2
1.56
1.63
%
0.03
45
541
188
2065
0.91
0.66
2.4
3.4
25.16
25.10
mmol/l
0.08
180
2000
18
129
1.40
0.63
1.1
1.2
—
—
—
0
0
23
301
0.76
0.61
1.5
1.7
53.30
51.07
nmol/l
0.13
23
281
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
0
22
0.00
0.59
0.0
4.9
—
—
—
0
0
29
366
0.79
0.59
2.3
3.1
—
—
—
0
0
7
116
0.60
0.57
1.0
1.0
—
—
—
0
0
13
183
0.71
0.55
1.2
1.3
76.77
100.94
u/l
0.78
13
155
91
804
1.14
0.55
1.9
2.2
191.17
81.81
ug/min
0.52
42
453
25
195
1.28
0.54
1.4
1.3
—
—
—
0
0
25
195
1.28
0.54
1.4
1.3
—
—
—
0
0
25
317
0.79
0.54
3.6
4.6
26.10
62.69
u/ml
2.42
25
310
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
25
316
0.79
0.53
1.4
1.5
—
—
—
0
0
16
117
1.37
0.52
1.7
1.4
119.00
93.82
umol/l
—
8
72
14
100
1.40
0.51
1.2
1.2
6.42
6.37
mmol/l
0.04
14
94
399
4198
0.94
0.50
3.8
6.0
94.77
95.01
%
0.23
379
4037
19
247
0.77
0.50
1.4
1.7
—
—
—
0
0
35
422
0.83
0.49
2.8
4.0
60.83
58.00
%
0.32
27
345
202
2172
0.93
0.49
1.9
2.4
0.64
0.63
%
0.13
202
2163
18
234
0.77
0.48
1.9
1.8
156.50
201.81
pmol/l
2.09
18
216
8
117
0.68
0.45
1.0
1.2
—
—
—
0
0
23
287
0.80
0.45
1.4
1.7
8.78
8.23
mmol/l
0.27
23
287
205
2194
0.93
0.45
2.0
2.5
1.10
1.09
%
0.09
205
2184
156
1441
1.09
0.44
2.4
2.5
35.73
22.54
au/ml
—
9
78
37
438
0.84
0.44
1.1
1.1
—
5.98
—
0
6
10
69
1.45
0.44
1.0
1.1
—
—
—
0
0
7
51
1.37
0.44
1.0
1.2
111.54
151.38
pmol/l
—
7
51
17
130
1.31
0.43
1.1
1.0
—
—
—
0
0
27
220
1.23
0.43
1.2
1.2
3.56
6.53
u/ml
—
9
113
142
1309
1.09
0.43
3.0
4.2
24.95
24.93
mmol/l
0.03
117
1148
13
174
0.75
0.43
1.2
1.3
27.15
27.37
u/l
0.01
13
143
32
382
0.84
0.42
2.4
2.2
5.52
1.51
u/field
2.29
25
191
6
95
0.63
0.42
1.2
1.7
86.17
96.01
%
—
6
88
104
947
1.10
0.41
1.2
1.3
—
—
—
0
0
18
228
0.79
0.41
1.3
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
6.26
—
0
16
572
5522
1.04
0.40
1.7
1.9
29.42
30.00
s
1.47
558
5323
1951
19776
0.97
0.40
23.4
28.0
13.92
14.15
%
11.58
1923
19449
8
61
1.31
0.39
1.6
1.6
72.13
646.03
nmol/24h
—
8
61
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
0.60
—
0
10
52
591
0.88
0.39
1.3
2.4
212.43
216.31
%
0.11
46
564
23
187
1.23
0.39
1.0
1.1
—
—
—
0
0
75
831
0.90
0.37
1.4
1.2
0.36
0.97
u/ml
0.60
13
69
12
158
0.76
0.37
1.3
2.0
—
—
—
0
0
61
681
0.89
0.35
1.2
1.2
—
—
—
0
0
5
78
0.64
0.35
1.4
1.3
—
—
—
0
0
29
245
1.19
0.35
1.8
1.5
145.36
107.09
ng/l
0.56
29
245
633
6146
1.04
0.35
3.5
3.4
1.31
1.37
e6/l
0.17
359
3428
47
414
1.14
0.34
1.6
1.3
263.81
273.17
mosm/kgh2o
1.92
32
283
37
320
1.16
0.34
1.3
1.2
15363.50
194157.62
e6/l
3.24
26
209
130
1396
0.93
0.34
2.8
3.0
4.45
4.27
pmol/l
1.61
112
1189
6
86
0.70
0.33
1.0
1.1
—
—
—
0
0
88
958
0.92
0.33
1.4
1.4
261.32
263.17
ug/g
0.03
51
593
789
7702
1.03
0.32
3.3
3.8
0.04
0.07
0.32
27
379
53
591
0.90
0.31
1.6
1.7
3.16
14.71
iu/l
0.52
16
209
56
503
1.12
0.31
2.0
2.4
32.60
23.82
mg/l
0.55
23
157
366
3799
0.96
0.31
4.0
6.4
121.60
118.36
g/l
2.37
360
3707
7
100
0.70
0.30
1.0
1.1
—
—
—
0
0
100
927
1.08
0.30
1.1
1.1
—
—
—
0
0
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
360
3471
1.04
0.30
3.3
5.7
1.44
1.44
mmol/l
0.01
347
3384
611
6271
0.97
0.29
1.5
1.6
1.51
1.66
mg/l
0.49
467
4985
95
1023
0.93
0.29
2.2
2.3
130.15
124.42
g/l
1.57
79
799
13
162
0.80
0.28
1.1
1.0
—
—
—
0
0
11
86
1.28
0.26
1.1
1.1
—
—
—
0
0
5
72
0.69
0.26
3.6
1.5
14.50
124.90
ug/l
—
5
66
13
160
0.81
0.26
1.0
1.2
—
—
—
0
0
1690
16714
1.02
0.25
4.0
6.1
12.80
12.74
umol/l
0.05
1571
15833
19
160
1.19
0.25
1.2
1.3
0.66
1.04
nmol/l
2.08
13
110
6
83
0.72
0.24
1.0
1.1
—
—
—
0
0
86
803
1.07
0.24
3.1
4.1
28.76
29.97
mg/l
0.15
67
594
515
5026
1.03
0.23
1.3
1.3
2.39
1.35
u/ml
0.85
132
1199
12
147
0.82
0.23
1.0
1.2
—
—
—
0
0
12
147
0.82
0.23
1.0
1.2
—
—
—
0
0
84
786
1.07
0.22
1.1
1.2
—
—
—
0
0
94
885
1.06
0.21
1.1
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
8
104
0.77
0.21
1.0
1.0
—
11.94
—
0
17
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
12
145
0.83
0.21
1.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
3.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
18
206
0.87
0.18
1.3
1.4
—
—
—
0
0
12
142
0.84
0.17
1.0
1.2
—
—
—
0
0
7
62
1.13
0.17
1.3
1.1
—
—
—
0
0
5
68
0.73
0.17
1.6
2.6
14.86
14.66
ml/dl
—
5
61
12
101
1.19
0.16
1.0
1.1
—
329.46
—
0
26
34
311
1.09
0.16
1.3
1.3
—
—
—
0
0
27
298
0.91
0.16
1.1
1.1
—
—
—
0
0
21
235
0.89
0.16
3.1
1.8
359.90
300.42
mu/l
0.45
21
212
24
266
0.90
0.15
1.0
1.4
—
—
—
0
0
24
266
0.90
0.15
1.0
1.4
—
—
—
0
0
24
266
0.90
0.15
1.0
1.4
—
—
—
0
0
82
780
1.05
0.15
1.1
1.2
—
—
—
0
0
18
159
1.13
0.15
1.1
1.4
—
—
—
0
0
18
159
1.13
0.15
1.1
1.4
—
—
—
0
0
18
159
1.13
0.15
1.1
1.4
—
—
—
0
0
18
159
1.13
0.15
1.1
1.4
—
—
—
0
0
14
121
1.16
0.15
1.0
1.0
131.07
135.26
nmol/l
0.14
14
121
144
1490
0.97
0.14
2.3
2.2
11.66
11.20
nmol/l
0.21
117
1245
7
90
0.78
0.14
1.3
1.1
—
—
—
0
0
34
314
1.08
0.14
1.4
1.2
—
—
—
0
0
12
139
0.86
0.14
1.8
1.7
50.18
55.31
ug/l
0.26
12
133
320
3135
1.02
0.13
2.7
3.4
82.98
97.12
ng/l
1.97
252
2568
1471
14818
0.99
0.13
4.3
5.7
0.19
0.20
e9/l
0.20
1247
12496
34
315
1.08
0.13
1.3
1.3
—
—
—
0
0
1457
14676
0.99
0.13
4.4
5.7
1.90
1.81
e9/l
0.38
1254
12522
28
304
0.92
0.13
1.0
1.5
—
—
—
0
0
34
365
0.93
0.12
1.5
1.4
75.88
66.16
%
1.44
25
235
18
199
0.90
0.11
1.3
1.4
—
—
—
0
0
87
903
0.96
0.11
1.3
1.3
—
—
—
0
0
36
338
1.07
0.10
1.1
1.3
—
—
—
0
0
82
851
0.96
0.10
1.5
1.5
13941.15
17174.87
e6/l
0.39
66
593
255
2593
0.98
0.09
4.4
5.7
24.38
24.41
mmol/l
0.04
245
2481
13
117
1.11
0.08
1.0
1.5
—
—
—
0
0
13
117
1.11
0.08
1.0
1.5
—
—
—
0
0
23
246
0.93
0.08
1.5
1.3
—
—
—
0
0
1629
16355
0.99
0.07
5.6
8.6
4.55
4.48
e9/l
0.46
1383
13939
9
85
1.06
0.07
1.4
1.3
32.04
29.02
umol/l
—
9
78
773
7782
0.99
0.07
2.2
2.6
—
—
—
0
0
13
118
1.10
0.07
1.2
1.1
—
—
—
0
0
38
396
0.96
0.06
1.6
1.6
1.63
5.00
mg/l
4.16
27
327
14
152
0.92
0.06
2.9
1.5
36.53
38.85
g/l
1.19
14
152
246
2489
0.99
0.05
4.5
7.3
92.82
93.55
%
0.78
246
2475
199
2015
0.99
0.05
3.4
4.2
1.02
1.02
ratio
0.01
176
1838
263
2604
1.01
0.05
2.0
2.1
397.72
398.01
nmol/l
0.01
227
2341
11
120
0.92
0.05
1.5
1.4
19.75
19.38
umol/l
0.01
11
108
13
120
1.08
0.04
1.0
1.5
—
—
—
0
0
30
288
1.04
0.04
1.4
1.2
—
—
—
0
0
91
926
0.98
0.04
1.3
1.4
—
—
—
0
0
91
926
0.98
0.04
1.3
1.4
—
—
—
0
0
262
2601
1.01
0.03
1.7
1.9
207.07
177.98
ug/g
0.47
190
2025
27
280
0.96
0.03
1.5
1.4
28.99
25.41
%
0.20
18
173
17
179
0.95
0.03
2.2
2.2
46.00
67.80
ug/min
—
5
45
19
181
1.05
0.03
1.1
1.1
120.46
112.90
%
0.36
13
161
302
3002
1.01
0.03
1.6
1.7
—
—
—
0
0
15
142
1.06
0.02
1.8
2.3
4.75
4.87
kpa
0.21
15
142
28
289
0.97
0.02
1.0
1.5
—
—
—
0
0
23
238
0.97
0.02
1.7
2.8
27.88
30.31
mg/l
0.11
17
185
69
699
0.99
0.01
1.4
1.5
1.15
1.15
g/l
0.02
64
662
15
143
1.05
0.01
1.1
1.2
—
—
—
0
0
15
143
1.05
0.01
1.1
1.2
—
—
—
0
0
15
143
1.05
0.01
1.8
2.3
9.43
10.03
kpa
0.45
15
143
367
3658
1.00
0.01
4.4
4.1
—
—
—
0
0
68
687
0.99
0.01
1.6
1.5
—
—
—
0
0
69
684
1.01
0.00
1.7
2.1
23.15
33.01
umol/l
4.60
54
584
18
178
1.01
0.00
1.0
1.2
—
—
—
0
0
15
155
0.97
0.00
1.1
1.0
—
—
—
0
0
16
155
1.03
0.00
1.3
1.3
—
—
—
0
0
409
4093
1.00
0.00
2.0
2.4
63.89
66.86
e9/l
1.13
321
3013
48
483
0.99
0.00
1.5
1.6
4.61
4.04
mmol/24h
0.56
36
399
11
113
0.97
0.00
1.2
1.1
—
—
—
0
0
16
157
1.02
0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
2.84
—
0
5
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
8
82
0.98
-0.00
1.3
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.01
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
61.82
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
7
78
0.90
-0.00
1.4
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
39.60
—
0
6
0
5
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
694.81
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ADMED_ACHEI_GALANTAMINE – Use of galantamine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).